newsfilter
← Latest News
GlobeNewswire·

Arvinas Employees Give Back During Company-wide Impact Day

NEW HAVEN, Conn., May 18, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company working to create a new class of drugs based on targeted protein degradation, today announced that